TORONTO,March 3,2025-- Recently,Visionary Holdings Inc. (hereinafter referred to as "Visionary",NASDAQ stock code: GV),a technology enterprise listed on the NASDAQ Capital Market,announced t

SAN FRANCISCO,March 3,2025--The convergence of artificial intelligence,zero-knowledge,and decentralized finance represents a transformative frontier in blockchain technology. By combining Zeko\'s zer

Proposal will expand MRI\'s presence in the Asia-Pacific real estate technology market and create future growth opportunities

BEIJING,March 4,2025-- TCTM Kids IT Education Inc. (NASDAQ: TCTM) ("TCTM" or the "Company"),a leading provider of IT-focused supplementary STEM education services in China,today an

Full development of the Starlab space station begins following the successful completion of the PDR,ensuring a seamless transition of activity from the International Space Station to commercial desti

STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]